The experience of rural independent pharmacies with medicare part D: reports from the field.

The experience of rural independent pharmacies with medicare part D: reports from the field. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

The experience of rural independent pharmacies with medicare part D: reports from the field. Abstract Text:

Andrea Radford,Rebecca Slifkin,Roslyn Fraser,Michelle Mason,Keith Mueller,

CONTEXT: The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) created prescription drug coverage for Medicare beneficiaries through a new Part D program, the single largest addition to Medicare since its creation in 1965. Prior to program implementation in January 2006, concerns had been voiced as to how independent pharmacies, which represent a higher proportion of all retail pharmacies in rural areas, would fare under the new program. PURPOSE: This article describes first-hand reports from rural pharmacist-owners about their experiences with Medicare Part D plans in the first 7 months of 2006 in order to gain a more thorough understanding of the challenges faced by rural independent pharmacies as a result of program implementation. METHODS: A semi-structured interview protocol was utilized in telephone interviews with 22 pharmacist-owners of rural independent pharmacies in 10 states. FINDINGS: The rural independent pharmacists interviewed are experiencing major changes in payment, administrative burden, and interaction with patients as a result of the shift of patients into Medicare Part D plans. While administrative burden has greatly increased, payment and clinical interaction have decreased. CONCLUSION: Actions should be considered that would help rural independent pharmacists adjust to the new circumstances of having Medicare patients mirror, for administrative and payment purposes, commercially insured patients. Long-term modification of existing policies and regulations may be necessary to assure reasonable access to pharmaceuticals for rural populations. Further study is needed to determine how best to target these modifications to essential pharmacies.

The experience of rural independent pharmacies with medicare part D: reports from the field. Publishing Authors By Initials

A Radford,R Slifkin,R Fraser,M Mason,K Mueller,

For similar geographic locations: americas: north america: united states research abstracts see: geographic locations: americas: north america: united states research

PUBMED ID PMID:

MEDLINE DATE:

The experience of rural independent pharmacies with medicare part D: reports from the field. Journal Published:

PUBLICATION TYPE: Research Support, U.S. Gov't,

Journal: The Journal of rural health : official journal of

VOLUME: 23

Page Numbers: 286-93

Journal Abbreviation:

ISSN: 0890-765X

DAY: 27

MONTH: 11

YEAR: 2007

The experience of rural independent pharmacies with medicare part D: reports from the field. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8508122

The experience of rural independent pharmacies with medicare part D: reports from the field. Keywords Mesh Terms:

KEYWORDS: United States

MESH TERMS:

Chemical & Substance for Abstract: The experience of rural independent pharmacies with medicare part D: reports from the field. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for The experience of rural independent pharmacies with medicare part D: reports from the field.

AFFILIATION: North Carolina Rural Health Research & Policy Analysis Center, Cecil G. Sheps Center for Health Services Research at the University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7590, USA. aradford@schsr.unc.edu

Country: United States

AGENCY: United States PHS

GRANT: U1CRH03714-01-00

ACRONYM:

MEDLINETA: J Rural Health

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

The experience of rural independent pharmacies with medicare part D: reports from the field Related Publications

• A case report of Clarkson's disease: If you don't know it, you'll miss it.
• Algorithms for on-line Differentiation of Neuroelectric Activities.
• Allopeptide-specific CD4(+) T cells facilitate the differentiation of directly alloreactive graft-infiltrating CD8(+) T Cells.
• An open trial of levetiracetam for segmental and generalized dystonia.
• Direct evidence for enzyme persulfide and disulfide intermediates during 4-thiouridine biosynthesis.
• Dosage in the treatment of pollinosis.
• Effect of footwear and orthotic devices on stress reduction and soft tissue strain of the neuropathic foot.
• Exercise training and sympathetic nervous system activity: evidence for physical activity dependent neural plasticity.
• Exercise training attenuates increases in lumbar sympathetic nerve activity produced by stimulation of the rostral ventrolateral medulla.
• Lattice-based volumetric global illumination.
• Low sex hormone-binding globulin as a predictive marker for insulin resistance in women with hyperandrogenic syndrome.
• Mitochondrial genome integrity mutations uncouple the yeast Saccharomyces cerevisiae ATP synthase.
• Molecular recognition of BMP-2 and BMP receptor IA.
• Non-catalytic function for ATR in the checkpoint response.
• Novel features of the rotary catalytic mechanism revealed in the structure of yeast F1 ATPase.
• Numerical simulation of the plantar pressure distribution in the diabetic foot during the push-off stance.
• Oleamide synthesizing activity from rat kidney: identification as cytochrome c.
• On the hemolytic and thrombogenic potential of occluder prosthetic heart valves from in-vitro measurements.
• Pioglitazone: an anti-diabetic compound with anti-aging properties.
• Real-time 3D computed tomographic reconstruction using commodity graphics hardware.
• TREM-1--expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases.
• The DNA binding parvulin Par17 is targeted to the mitochondrial matrix by a recently evolved prepeptide uniquely present in Hominidae.
• The amide rotational barrier in isonicotinamide: Dynamic NMR and ab initio studies.
• The experience of rural independent pharmacies with medicare part D: reports from the field.
• The risk of malarial infections and disease in Papua New Guinean children.
• The use of B-type natriuretic peptides in the intensive care unit.
• Trace element removal during in vitro and in vivo continuous haemodialysis.
• Transcriptional dysregulation during myeloid transformation in AML.
• Vaccines against malaria - an update.
• Virus infection causes specific learning deficits in honeybee foragers.